RFC
BHVN

Regions Financial Corp’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Regions Financial Corp’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,327
Closed -$339K – 883
2022
Q2 		$339K Buy
2,327
+584
+34% +$74.6K ﹤0.01% 677
2022
Q1 		$206K Buy
+1,743
New +$217K ﹤0.01% 867
2019
Q2 		– Sell
-100
Closed -$5K – 1998
2019
Q1 		$5K Hold
100
– – ﹤0.01% 1683
2018
Q4 		$4K Hold
100
– – ﹤0.01% 1692
2018
Q3 		$4K Hold
100
– – ﹤0.01% 1772
2018
Q2 		$4K Hold
100
– – ﹤0.01% 1845
2018
Q1 		$3K Hold
100
– – ﹤0.01% 1846
2017
Q4 		$3K Buy
+100
New +$2.75K ﹤0.01% 1879

Other funds holding BHVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Regions Financial Corp's BHVN Position: Q3 2022 in Review

Regions Financial Corp sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2022, closing a stake of 2,327 shares — an estimated $339K sold.

Regions Financial Corp first reported a position in BHVN in Q4 2017 and held it in 8 quarters. The position peaked at $339K in Q2 2022. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

  • Regions Financial Corp reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2022 after selling out during the quarter.
  • Regions Financial Corp sold 2,327 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $339K.
  • Regions Financial Corp first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2017 and held it in 8 quarters.
  • Regions Financial Corp's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $339K in Q2 2022.
  • 240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on Regions Financial Corp's 13F filing for Q3 2022, filed 3 Nov 2022.